Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Glaukos Corporation

http://www.glaukos.com/

Latest From Glaukos Corporation

Alcon Sees Big Opportunity In Glaucoma Surgery; Buys Ivantis For $475M

Ivantis markets the Hydrus Microstent for minimally invasive glaucoma surgery, a field Alcon exited three years ago when it pulled its CyPass from the market

M & A Ophthalmology

CMS Advisory Panel Provides Some Potential Good News For Glaukos

Rate adjustment recommendations to US Medicare could result in less drastic reimbursement cuts for Glaukos than those currently on the table.

Medicare Reimbursement

Glaukos Takes Another Hit From CMS; Investors Respond Negatively As Stock Falls

The US Medicare agency's new rule for facility fees brings more bad news for Glaukos; Wells Fargo downgrades company’s stock in response.

Reimbursement Medicare

Latest Physician Fee Schedule Proposal Could Impact Companies’ Bottom Line

The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes new reimbursement levels for multiple medical devices, including the Glaukos iStent.

Medicaid Medicare
See All

Company Information

UsernamePublicRestriction

Register